Crohn’s disease patients have specific IgG antibodies to human bacterial flagellins
Closed incision negative pressure wound therapy versus standard dressings in obese women undergoing caesarean section: multicentre parallel group randomised controlled trial
5 May 2021‘Chameleon effect’ and smartphone use: Spontaneous mimicry in social situations
5 May 2021Crohn’s disease patients have specific IgG antibodies to human bacterial flagellins
Last year, Charles O. Elson, M.D., demonstrated a potential preventive treatment for Crohn’s disease, a form of inflammatory bowel disease. He used a mouse model that included immune-reactive T cells from patients with Crohn’s disease in a flagellin peptide-specific immunotherapy. This study provided proof-of-principle that a flagellin-directed immunotherapy might provide similar benefits in patients.
